Waters Parkerson & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$897K Buy
10,400
+3,010
+41% +$265K 0.04% 110
2026
Q2
$578K Buy
7,390
+187
+3% +$15.1K 0.03% 134
2026
Q1
$624K Hold
7,203
– – 0.03% 122
2025
Q4
$692K Hold
7,203
– – 0.03% 120
2025
Q3
$686K Hold
7,203
– – 0.03% 120
2025
Q2
$628K Hold
7,203
– – 0.03% 121
2025
Q1
$647K Buy
7,203
+250
+4% +$22.4K 0.03% 122
2024
Q4
$555K Buy
6,953
+1,750
+34% +$151K 0.03% 129
2024
Q3
$468K Sell
5,203
-125
-2% -$10.5K 0.02% 138
2024
Q2
$419K Buy
+5,328
New +$437K 0.02% 132
2021
Q1
– Sell
-3,663
Closed -$429K – 176
2020
Q4
$429K Buy
+3,663
New +$403K 0.03% 127

Other funds holding MDT

Waters Parkerson & Co's MDT Position: Q3 2026 in Review

Waters Parkerson & Co increased its Medtronic (MDT) stake by 41% in Q3 2026, buying an estimated $265K and bringing the position to 10,400 shares worth $897K. The position accounts for 0.04% of the portfolio, ranked #110.

Waters Parkerson & Co first reported a position in MDT in Q4 2020 and has held it in 11 quarters since. 2,197 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Waters Parkerson & Co held 10,400 shares of Medtronic worth $897K as of Q3 2026.
  • Waters Parkerson & Co bought 3,010 Medtronic shares in Q3 2026, an estimated $265K.
  • Medtronic made up 0.04% of Waters Parkerson & Co's portfolio in Q3 2026, its #110 holding.
  • Waters Parkerson & Co first reported a position in Medtronic in Q4 2020 and has held it in 11 quarters since.
  • 2,197 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Waters Parkerson & Co's 13F filing for Q3 2026, filed 4 Nov 2026.